• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎患者心血管疾病及传统心血管危险因素的流行情况:来自 BioSTAR 全国注册登记研究的真实证据。

Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.

机构信息

Division of Rheumatology, Department of Physical Medicine and Rehabilitaton, Faculty of Medicine, Marmara University, İstanbul, Türkiye.

Division of Rheumatology, Department of Physical Medicine and Rehabilitaton, Faculty of Medicine, Ankara University, Ankara, Türkiye.

出版信息

Rheumatol Int. 2024 Feb;44(2):291-301. doi: 10.1007/s00296-023-05515-y. Epub 2023 Dec 29.

DOI:10.1007/s00296-023-05515-y
PMID:
38157014
Abstract

Patients with rheumatoid arthritis (RA) have increased morbidity and mortality due to cardiovascular (CV) comorbidities. The association of CV diseases (CVD) and traditional CV risk factors has been debated, depending on patient and RA characteristics. This study aimed to find the prevalence of CVD and CV risk factors in patients with RA. A multi-center cross-sectional study was performed on RA patients using the BioSTAR (Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs Registry) in September 2022. Socio-demographic, clinical, and follow-up data were collected. Myocardial infarction, ischemic heart disease, peripheral vascular disorders, congestive heart failure, ischemic stroke, and transient ischemic attack were regarded as major adverse cardiovascular events (MACEs). CVD was defined as the presence of at least one clinical situation of MACE. Group 1 and Group 2 included patients with and without CVD. Prevalence rates of CVD and traditional CV risk factors were the primary outcomes. Secondary outcomes were the differences in the clinical characteristics between patients with and without CVD. An analysis of 724 patients with a mean age of 55.1 ± 12.8 years diagnosed with RA was conducted. There was a female preponderance (79.6%). The prevalence rate of CVD was 4.6% (n = 33). The frequencies of the diseases in the MACE category were ischemic heart disease in 27, congestive heart failure in five, peripheral vascular disorders in three, and cerebrovascular events in three patients. The patients with CVD (Group 1) were significantly male, older, and had higher BMI (p = 0.027, p < 0.001, and p = 0.041). Obesity (33.4%) and hypertension (27.2%) were the two CV risk factors most frequently. Male sex (HR = 7.818, 95% CI 3.030-20.173, p < 0.001) and hypertension (HR = 4.570, 95% CI 1.567-13.328, p = 0.005) were the independent risk factors for CVD. The prevalence of CVD in RA patients was 4.6%. Some common risk factors for CVD in the general population, including male sex, older age, and hypertension, were evident in RA patients. Male sex and hypertension were the independent risk factors for developing CVD in patients with RA.

摘要

类风湿关节炎(RA)患者由于心血管(CV)合并症而导致发病率和死亡率增加。CV 疾病(CVD)与传统 CV 危险因素之间的关联一直存在争议,具体取决于患者和 RA 的特征。本研究旨在探讨 RA 患者 CVD 和 CV 危险因素的患病率。2022 年 9 月,使用 BioSTAR(生物和靶向合成疾病修饰抗风湿药物登记处)对 RA 患者进行了一项多中心横断面研究。收集了社会人口统计学、临床和随访数据。心肌梗死、缺血性心脏病、外周血管疾病、充血性心力衰竭、缺血性中风和短暂性脑缺血发作被视为主要不良心血管事件(MACEs)。CVD 定义为至少存在一种 MACE 临床情况。第 1 组和第 2 组包括有和没有 CVD 的患者。CVD 和传统 CV 危险因素的患病率是主要结局。次要结局是有和没有 CVD 的患者之间临床特征的差异。对 724 名平均年龄为 55.1±12.8 岁的 RA 患者进行了分析。女性占优势(79.6%)。CVD 的患病率为 4.6%(n=33)。MACE 类别中的疾病频率分别为 27 例缺血性心脏病、5 例充血性心力衰竭、3 例外周血管疾病和 3 例脑血管事件。CVD 患者(第 1 组)的男性明显较多,年龄较大,BMI 较高(p=0.027,p<0.001 和 p=0.041)。肥胖(33.4%)和高血压(27.2%)是最常见的两种 CV 危险因素。男性(HR=7.818,95%CI 3.030-20.173,p<0.001)和高血压(HR=4.570,95%CI 1.567-13.328,p=0.005)是 CVD 的独立危险因素。RA 患者 CVD 的患病率为 4.6%。一些普通人群 CVD 的常见危险因素,包括男性、年龄较大和高血压,在 RA 患者中也很明显。男性和高血压是 RA 患者发生 CVD 的独立危险因素。

相似文献

1
Prevalence of cardiovascular diseases and traditional cardiovascular risk factors in patients with rheumatoid arthritis: a real-life evidence from BioSTAR nationwide registry.类风湿关节炎患者心血管疾病及传统心血管危险因素的流行情况:来自 BioSTAR 全国注册登记研究的真实证据。
Rheumatol Int. 2024 Feb;44(2):291-301. doi: 10.1007/s00296-023-05515-y. Epub 2023 Dec 29.
2
Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: a real-life evidence from biostar nationwide registry.脊柱关节炎患者心血管疾病及相关危险因素的横断面分析:来自生物之星全国注册登记研究的真实世界证据。
Rheumatol Int. 2024 Apr;44(4):631-642. doi: 10.1007/s00296-023-05523-y. Epub 2024 Feb 6.
3
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study.类风湿关节炎患者的心血管疾病:QUEST-RA研究结果
Arthritis Res Ther. 2008;10(2):R30. doi: 10.1186/ar2383. Epub 2008 Mar 6.
4
[Occurrence of cardiovascular events within a large population of patients affected by rheumatoid arthritis with or without diabetes.].[类风湿关节炎患者(伴或不伴糖尿病)大群体中心血管事件的发生情况。]
Recenti Prog Med. 2023 Feb;114(2):94-109. doi: 10.1701/3966.39449.
5
Association of cardiovascular disease and traditional cardiovascular risk factors with the incidence of dementia among patients with rheumatoid arthritis.类风湿关节炎患者心血管疾病和传统心血管危险因素与痴呆发病率的关系。
Semin Arthritis Rheum. 2021 Feb;51(1):292-298. doi: 10.1016/j.semarthrit.2020.09.022. Epub 2021 Jan 5.
6
Subcutaneous nodules are associated with cardiovascular events in patients with rheumatoid arthritis: results from a large US registry.皮下结节与类风湿关节炎患者的心血管事件相关:来自美国一项大型登记研究的结果
Clin Rheumatol. 2015 Oct;34(10):1697-704. doi: 10.1007/s10067-015-3032-9. Epub 2015 Aug 5.
7
Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study.类风湿关节炎心血管风险预测评分的推导和内部验证:北美风湿病研究联合会注册研究。
Arthritis Rheumatol. 2015 May;67(8):1995-2003. doi: 10.1002/art.39195.
8
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.类风湿关节炎与 2 型糖尿病心血管事件风险比较:一项长达 15 年的纵向研究。
J Rheumatol. 2020 Mar;47(3):316-324. doi: 10.3899/jrheum.180726. Epub 2019 May 15.
9
Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study.早期类风湿关节炎的心血管危险因素和结局:一项基于人群的研究。
Heart. 2020 Oct;106(20):1566-1572. doi: 10.1136/heartjnl-2019-316193. Epub 2020 Mar 24.
10
Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.类风湿关节炎中的心血管疾病:中国的药物与风险因素
Clin Rheumatol. 2017 May;36(5):1023-1029. doi: 10.1007/s10067-017-3596-7. Epub 2017 Mar 24.

引用本文的文献

1
Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018.尿白蛋白与肌酐比值预测类风湿关节炎患者全因死亡率和特定原因死亡率的风险:来自1999 - 2018年美国国家健康与营养检查调查的证据
Clin Rheumatol. 2025 Feb;44(2):623-633. doi: 10.1007/s10067-024-07272-0. Epub 2024 Dec 30.
2
Subclinical left ventricular dysfunction in rheumatoid arthritis: findings from the prospective Porto-RA cohort.类风湿关节炎中的亚临床左心室功能障碍:来自前瞻性波尔图类风湿关节炎队列研究的结果
Clin Res Cardiol. 2024 Sep 30. doi: 10.1007/s00392-024-02548-6.
3

本文引用的文献

1
Assessing the accuracy and completeness of artificial intelligence language models in providing information on methotrexate use.评估人工智能语言模型在提供甲氨蝶呤使用信息方面的准确性和完整性。
Rheumatol Int. 2024 Mar;44(3):509-515. doi: 10.1007/s00296-023-05473-5. Epub 2023 Sep 25.
2
Vascular effects of biologic and targeted synthetic antirheumatic drugs approved for rheumatoid arthritis: a systematic review.生物制剂和靶向合成抗风湿药物治疗类风湿关节炎的血管效应:系统评价。
Clin Rheumatol. 2023 Oct;42(10):2651-2676. doi: 10.1007/s10067-023-06587-8. Epub 2023 Mar 30.
3
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.
Rheumatoid arthritis, cardiometabolic comorbidities, and related conditions: need to take action.
类风湿关节炎、心脏代谢合并症及相关病症:需采取行动。
Front Med (Lausanne). 2024 Jul 24;11:1421328. doi: 10.3389/fmed.2024.1421328. eCollection 2024.
4
Association between the advanced lung cancer inflammation index and all-cause and cardiovascular mortality in patients with RA: Insights from NHANES data analysis.类风湿关节炎患者中晚期肺癌炎症指数与全因死亡率和心血管死亡率之间的关联:来自美国国家健康与营养检查调查数据分析的见解
Heliyon. 2024 Jun 27;10(13):e33673. doi: 10.1016/j.heliyon.2024.e33673. eCollection 2024 Jul 15.
生物制剂和靶向合成改善病情抗风湿药物在类风湿关节炎临床应用中的安全性:来自 ARTIS 研究计划的结果。
Ann Rheum Dis. 2023 May;82(5):601-610. doi: 10.1136/ard-2022-223762. Epub 2023 Feb 14.
4
Cardiovascular Risk Factors before Onset of Rheumatoid Arthritis Are Associated with Cardiovascular Events after Disease Onset: A Case-Control Study.类风湿关节炎发病前的心血管危险因素与疾病发病后的心血管事件相关:一项病例对照研究。
J Clin Med. 2022 Nov 3;11(21):6535. doi: 10.3390/jcm11216535.
5
Accelerated atherosclerosis in rheumatoid arthritis: a systematic review.类风湿关节炎患者的动脉粥样硬化加速:系统评价。
F1000Res. 2022 Apr 27;11:466. doi: 10.12688/f1000research.112921.2. eCollection 2022.
6
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.静脉血栓栓塞症与 JAK 抑制剂和其他免疫调节药物:一项在类风湿关节炎患者中进行的瑞典比较安全性研究。
Ann Rheum Dis. 2023 Feb;82(2):189-197. doi: 10.1136/ard-2022-223050. Epub 2022 Sep 23.
7
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.托法替尼与肿瘤坏死因子抑制剂治疗伴或不伴动脉粥样硬化性心血管疾病史的类风湿关节炎患者的主要不良心血管事件风险:来自 ORAL Surveillance 的事后分析。
Ann Rheum Dis. 2023 Jan;82(1):119-129. doi: 10.1136/ard-2022-222259. Epub 2022 Sep 22.
8
A Clinical Audit of Cardiovascular Risk Factors and Disease in Patients with Rheumatoid Arthritis - SURF-RA.类风湿关节炎患者心血管危险因素与疾病的临床审计——SURF-RA研究。
Mediterr J Rheumatol. 2022 Jun 30;33(2):201-217. doi: 10.31138/mjr.33.2.201. eCollection 2022 Jun.
9
Is the Calcium Score Useful for Rheumatoid Arthritis Patients at Low or Intermediate Cardiovascular Risk?钙评分对低或中度心血管风险的类风湿关节炎患者有用吗?
J Clin Med. 2022 Aug 18;11(16):4841. doi: 10.3390/jcm11164841.
10
The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.类风湿关节炎患者心血管疾病风险预测评分的比较及亚临床动脉粥样硬化的评估:一项横断面研究。
Clin Rheumatol. 2022 Dec;41(12):3675-3686. doi: 10.1007/s10067-022-06349-y. Epub 2022 Aug 25.